|
Status |
Public on Jul 07, 2020 |
Title |
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Other Non-coding RNA profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
32719445 |
|
Submission date |
Feb 19, 2019 |
Last update date |
Jul 30, 2020 |
Contact name |
Danny Misiak |
E-mail(s) |
[email protected]
|
Phone |
+49345573962
|
Organization name |
Martin Luther University Halle-Wittenberg
|
Department |
Molecular Cell Biology
|
Lab |
Hüttelmaier Lab
|
Street address |
Kurt-Mothes-Str. 3a
|
City |
Halle (Saale) |
ZIP/Postal code |
06120 |
Country |
Germany |
|
|
Platforms (2) |
GPL15456 |
Illumina HiScanSQ (Homo sapiens) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (54)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE126698 |
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis [RNA-Seq] |
GSE126728 |
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis [sWGS] |
|
Relations |
BioProject |
PRJNA523129 |